Role of re-resection in non-muscle-invasive bladder cancer

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 283-288

  Herr, Harry W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bladder tumors; Restaging; Transurethral resection

Indexed keywords

BLADDER CANCER; CANCER RECURRENCE; CANCER STAGING; DIAGNOSTIC ERROR; HUMAN; PATIENT SELECTION; REOPERATION; REVIEW; RISK REDUCTION; TREATMENT INDICATION; TREATMENT OUTCOME;

HUMANS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; URINARY BLADDER NEOPLASMS;

EID: 79952407187     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.29     Document Type: Review

References (20)

1. Herr, H.W. and Donat, S.M. (2008) Quality control in transurethral resection of bladder tumors. BJU Int.102, 1242-1246.
2. Bubjuk, M., Oosterlinck, W., Sylvester, R., et al. (2008) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur. Urol.54, 303-314.
3. Maruniak, N.A. et al. (2002) Accurate pathologic staging of urothelial neoplasms requires better cystoscopic sampling. J. Urol. 167, 2404-2407. (Pubitemid 34533134)
4. Babjuk, M. (2010) Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives. Eur. Urol. 58, 191-192.
5. Raj, G. et al. (2007) Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. J. Urol.177, 1283-6. (Pubitemid 46435978)
6. Herr, H.W. et al. (2007) Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J. Urol. 177, 75-79. (Pubitemid 44879466)
7. Dalbagni, G. et al. (2009) Clinical outcome in a contemporary series of restaged patients with T1 bladder cancer. Eur. Urol.56, 903-910.
8. Guevara, A. et al. (2010) The role of tumor-free status in repeat resection before intravesical BCG for high grade Ta, T1 and CIS bladder cancer. J. Urol. 183, 2161-2164.
9. Grimm, M.-C. et al. (2003) Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J. Urol. 170, 433-7.
10. Herr, H.W. (2005) Restaging TUR of high risk superficial bladder cancer improves the initial response to BCG therapy. J. Urol. 174, 2134-2137.
11. Divrik, R.T. et al. (2010) Impact of routine second TUR on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomized clinical trial. Eur. Urol.58, 185-190.
12. Novara, G. et al. (2010) Does routine second TUR affect long-term outcome of patients with T1 bladder cancer? Why a flawed randomized controlled trial cannot address the issue. Eur. Urol.58, 193-194.
13. Dalbagni, G. et al. (2010) Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma. BJU Int.106, 1502-1507.
14. Brausi, M.A. et al. (2002) Variability in the recurrence rate at the first follow-up cystoscopy after TUR in stage TaT1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur. Urol.41, 523-531.
15. Zurkirchen, M.A. et al. (2004) Second TUR of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists. Urol. Int. 72, 99-102. (Pubitemid 38223792)
16. Koloszy, Z. (1991) Histopathological "self control" in transurethral resection of bladder tumors. BJU Int.67, 162-164.
17. Dalbagni, G. et al. (2002) Impact of a second transurethral resection on staging of T1 bladder cancer. Urology60, 822-825.
18. Pycha, A. et al. (2007) How to teach the teacher to teach the TUR-B. Int. J. Surg. 5, 81-85. (Pubitemid 46590851)
19. Herr, H.W. et al. (2006) A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int. 97, 1194-1198. (Pubitemid 43907320)
20. Orsola, A. et al. (2009) Letter to editor. Eur. Urol.55, e15-16.